Efficient identification of de novo mutations in family trios: a consensus-based informatic approach
Accurate identification of de novo variants (DNVs) remains challenging despite advances in sequencing technologies, often requiring ad hoc filters and manual inspection. Here, we explored a purely informatic, consensus-based approach for identifying DNVs in proband-parent trios using short-read genome sequencing data. We evaluated variant calls generated by three sequence analysis pipelines-GATK HaplotypeCaller, DeepTrio, and Velsera GRAF-and examined the assumption that a requirement of consensus can serve as an effective filter for high-quality DNVs. Comparison with a highly accurate DNV set, validated previously by manual inspection and Sanger sequencing, demonstrated that consensus filtering, followed by a force-calling procedure, effectively removed false-positive calls, achieving 98.0-99.4% precision. At the same time, sensitivity of the workflow based on the previously established DNVs reached 99.4%. Validation in the HG002-3-4 Genome-in-a-Bottle trio confirmed its robustness, with precision reaching 99.2% and sensitivity up to 96.6%. We believe that this consensus approach can be widely implemented as an automated bioinformatics workflow suitable for large-scale analyses without the need for manual intervention, especially when very high precision is valued over sensitivity.
Authors
- Christine E. Seidman (ORCID: https://orcid.org/0000-0001-6380-1209)
- Sinem Demirkaya-Budak (ORCID: https://orcid.org/0000-0003-3500-2682)
- Deniz Turgut (ORCID: https://orcid.org/0000-0003-0543-3561)
- Wendy K. Chung (ORCID: https://orcid.org/0000-0003-3438-5685)
- Mariya Shadrina (ORCID: https://orcid.org/0000-0001-5962-0771)
- Charles A. LeDuc (ORCID: https://orcid.org/0000-0002-2073-5050)
- Güngör Budak (ORCID: https://orcid.org/0000-0003-1641-3304)
- Özem Kalay
- Brandi N. Davis‐Dusenbery (ORCID: https://orcid.org/0000-0001-7811-8613)
- H. Joseph Yost (ORCID: https://orcid.org/0000-0003-2961-5669)
- Bruce D. Gelb (ORCID: https://orcid.org/0000-0001-8527-5027)
- Vladimir Semenyuk (ORCID: https://orcid.org/0000-0002-7461-6153)
- Anil Jain (ORCID: https://orcid.org/0009-0002-5162-1213)
- Elif Arslan (ORCID: https://orcid.org/0000-0003-4198-9196)
Institutions
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- University of Utah (US)
- New York Proton Center (US)
- Child Health and Development Institute (US)
- Short and Associates (United States) (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Life Science Alliance
- Published
- 2025-03-28
- DOI
- https://doi.org/10.26508/lsa.202403039
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences